Daniel CODALLOS, JR.,Robert ORR,Ching-Yuan LI,Valerie Denise START
申请号：
US16746644
公开号：
US20200163892A1
申请日:
2020.01.17
申请国别(地区):
US
年份:
2020
代理人:
摘要：
Disclosed herein are pharmaceutical compositions and dosage forms including N-[5-(3,5-difluorobenzyl)-1H-indazol-3-yl]-4-(4-methyl-piperazin-1-yl)-2-(tetrahydro-2H-pyran-4-ylamino) benzamide that are useful in the treatment of subjects having cancer. The present disclosure also provides methods for preparing these pharmaceutical compositions and dosage forms, and methods of treating subjects having cancer utilizing the pharmaceutical compositions and dosage forms provided herein.
